References

• Abdou, H. (1989). Theory of dissolution. In: Dissolution, Bioavailability & Bioequivalence. Easton: MACK Publishing Company: 11–36
• Blanchard, J. (1978). Gastrointestinal absorption II. Formulation factors affecting drug bioavailability. PubMed, 150(5), 132–151.
• Chen, X., Antman, M., Gesenberg, C., & Gudmundsson, O. (2006). Discovery pharmaceutics—Challenges and opportunities. The AAPS Journal, 8(2), E402–E408.
• Gibson, M. (2009), Pharmaceutical Pre-formulation and Formulation-A Practical Guide from Candidate Drug Selection to Commercial Dosage Form, 2nd Ed. Informa Healthcare USA Inc., New York, NY 10017:129-170
• Henck, J., & Byrn, S. R. (2007). Designing a molecular delivery system within a preclinical timeframe. Drug Discovery Today, 12(5–6), 189–199.
• Hintz, R. J., & Johnson, K. C. (1989). The effect of particle size distribution on dissolution rate and oral absorption. International Journal of Pharmaceutics, 51(1), 9–17.
• Ingels, F., Ungell, A., & Augustijns, P. (2007). Selection of solvent systems for membrane-, cell- and Tissue-Based permeability assessment. In Springer eBooks (pp. 179–220).
• Kerns, E. H. (2001). High throughput physicochemical profiling for drug discovery. Journal of Pharmaceutical Sciences, 90(11), 1838–1858.
• Ketan T. Savjani, Anuradha K. Gajjar, and Jignasa K. Savjani (2012). Drug Solubility: Importance and Enhancement Techniques, v.2012, 195727.
• Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014). Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian Journal of Pharmaceutical Sciences, 9(6), 304–316.
• Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235–249.
• Oberle, R. L., Moore, T. J., & Krummel, D. a. P. (1995). Evaluation of mucosal damage of surfactants in rat jejunum and colon. Journal of Pharmacological and Toxicological Methods, 33(2), 75–81.
• Shargel, L., Andrew, B. C. Y (1980). Applied Biopharmaceutics and Pharmacokinetics, 7th edition; chapter 14: 448-488
• Smith, Blaine Templar (2016). Remington Education: Physical Pharmacy, First Edition, And Chapter 3:31-15